Close

Dynavax (DVAX) Announces Presentation of Early Data from SD-101 Combo Phase 1b/2; ORs Noted in 80% of Patients

Go back to Dynavax (DVAX) Announces Presentation of Early Data from SD-101 Combo Phase 1b/2; ORs Noted in 80% of Patients